New Life vs ACASA Senior Care

ACASA Senior Care is the clear pick, and it starts with budget. At $6.9M AUV, each unit has the revenue base to absorb a multi-module software stack—POS, scheduling, back-office—without the vendor fighting for scraps. Compare that to New Life, which doesn’t even report AUV and carries a higher investment ceiling ($202K) with no proven unit economics. ACASA’s lower investment range ($83K–$134K) paired with high revenue signals healthier margins and faster ROI on technology spend. For a vendor, that means shorter sales cycles and less pushback on price.

TAM and terrain tilt further toward ACASA. Seven franchised units and 40% unit growth give you a real, expanding footprint to sell into, plus a corporate structure that can drive top-down adoption. New Life has zero franchised units—it’s a pure startup play with no existing operator base to seed referrals or case studies. ACASA’s approved-supplier procurement model also means you can get on the list and lock out competitors early, whereas New Life’s overdue FDD filing signals operational disarray that will delay any vendor evaluation. The only tradeoff is royalty rate: New Life charges 6% versus ACASA’s 5%, which could theoretically squeeze operator tech budgets, but without AUV data or open units, that’s a phantom concern.

Timing seals it. ACASA’s 2025 FDD is current, so you can engage procurement now with compliant, up-to-date materials. New Life’s overdue filing means you’re selling into a black box—no franchisor will greenlight a software deal while their legal docs are stale. You’d burn cycles waiting for an update that may never come.

Verdict: ACASA Senior Care wins on budget depth, TAM momentum, and procurement readiness; New Life is a speculative bet with no near-term path to revenue.